Skip to main content
Log in

Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The results of treating 12 consecutive patients with unresectable colorectal hepatic metastases with a hepatic arterial infusion of high-dose Adriamycin, 100–120 mg/m2, using hepatic venous isolation (HVI) and charcoal hemoperfusion (CHP) are reported herein. Adriamycin was administered over 5–15 min under extracorporeal drug elimination by HVI-CHP. HVI was percutaneously accomplished by either the double-balloon technique using a Fogarty occlusion catheter (8/22F) or a balloon-tipped catheter (16F). During the infusion, isolated hepatic venous blood was filtered by CHP and pumped into the left axillary vein. There were no lethal complications, and good hemodynamic tolerance to HVI-CHP was confirmed. Tumor liquefaction accompanied by a sharp decrease in serum carcinoembryonic antigen levels by more than 50% of pretreatment levels was observed in 6 of the 12 patients 1 month after treatment. Apart from chemical hepatitis, which developed in 11 (92%) of the patients, the Adriamycin toxicities were well controlled following the development of nausea and vomiting in 2 patients (17%), leukopenia <2,000/mm3 in 3 (25%), and gastric ulcer in 1 (8%). These results indicate that this method is a safe and useful procedure for otherwise hazardous high-dose intraarterial chemotherapy in patients with unresectable hepatic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leff RS, Thompson JM, Johnson DB, Mosley KR, Daly MB, Knights Wa III, Ruxe RL Jr, Messerchmidt GL (1986) Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma. J Clin Oncol 4:1586–1591

    Google Scholar 

  2. Frei III E, Canellos GP (1980) Dose: a critical factor in cancer chemotherapy. Am J Med 69:585–594

    Google Scholar 

  3. Aigner KR, Müller H, Walther H, Link KH (1988) Drug filtration in high-dose regional chemotherapy. Contrib Oncol 29:261–280

    Google Scholar 

  4. Kamidono S, Fujii A, Hamami G, Nakano Y, Umezu K, Oda Y, Ishigami J (1984) New preoperative chemotherapy for bladder cancer using combination hemodialysis and direct hemoperfusion: preliminary report. J Urol 131:36–40

    Google Scholar 

  5. Aigner KR, Walther H, Link KH (1988) Isolated liver perfusion with MMC/5-FU: surgical technique, pharmacokinetics, clinical results. Contrib Oncol 29:229–246

    Google Scholar 

  6. Ku Y, Saitoh M, Nishiyama H, Fujiwara S, Iwasaki T, Tominaga M, Maekawa Y, Ohyanagi H, Saitoh Y (1990) Extracorporeal removal of anticancer drugs in hepatic artery infusion: the effect of direct hemoperfusion combined with veno-venous bypass. Surgery 107:273–281

    Google Scholar 

  7. Maekawa Y, Ku Y, Saitoh Y (1993) Extracorporeal cisplatin removal using direct hemoperfusion under hepatic venous isolation for hepatic arterial chemotherapy: an experimental study on pharmacokinetics. Surg Today 23:58–62

    Google Scholar 

  8. Ku Y, Saitoh M, Iwasaki T, Tominaga M, Maekawa Y, Shiki H, Samizo M, Fukumoto T, Kuroda Y, Sako M, Okada M, Saitoh Y (1993) Intraarterial high-dose chemotherapy for unresectable hepatocellular carcinoma using direct hemoperfusion under hepatic venous isolation. Eur J Surg Oncol 19:387–392

    Google Scholar 

  9. Ku Y, Saitoh Y (1994) Extracorporeal carbon chemofiltration under hepatic venous isolation for high-dose intraarterial chemotherapy of the liver. Surgery 116:941

    Google Scholar 

  10. Ku Y, Fukumoto T, Iwasaki T, Tominaga M, Samizo M, Nishida T, Kuroda Y, Hirota S, Sako M, Obara H, Saitoh Y (1995) Clinical pilot study on high-dose intraarterial chemotherapy using direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. Surgery 117:510–519

    Google Scholar 

  11. Weber J, Novak D (1980) Occlusion arteriography: diagnostic and therapeutic applicability of balloon catheters. Cardiovasc Intervent Radiol 3:81–96

    Google Scholar 

  12. Kawabata M, Takashima S, Mitsuzane K, Tanaka M, Maeda C, Hamachi J, Nomura S, Matsuoka T, Kobayashi N, Sato M, Nakatsuka H, Yamada R (1984) Balloon-occluded arterial infusion therapy for malignant hepatic tumors (in Japanese). Jpn J Cancer Chemother 11:806–813

    Google Scholar 

  13. Creech O Jr, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:612–632

    Google Scholar 

  14. Mulcare RJ, Solis A, Fortner JG (1973) Isolation and perfusion of the liver for cancer chemotherapy. J Surg Res 15:87–95

    Google Scholar 

  15. Chen HG, Gross IF (1980) Intraarterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64:31–40

    Google Scholar 

  16. Hirose H, Aoyama M, Oshima K, Udo K, Kobayashi S, Adachi N, Nonaka T, Yamada T (1982) Chemotherapy for patients with hepatocellular carcinoma: clinical evaluation of high-dose Adriamycin regimen with intraarterial infusion (in Japanese). Jpn J Cancer Chemother 9:216–2221

    Google Scholar 

  17. Kemeny N, Daly J, Oderman P, Shike M, Chun H, Petroni G, Geller N (1982) Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 2:595–600

    Google Scholar 

  18. Safi F, Bittner R, Roscher R, Schumacher K, Gaus W, Gunter H, Beger H (1980) Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous/intravenous therapy). Cancer 64:379–387

    Google Scholar 

  19. Kemeny MM, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, Margolin KA, Terz JJ (1985) Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 202:176–181

    Google Scholar 

  20. Ku Y, Samizo M, Fukumoto T, Shiki H, Maekawa Y, Iwasaki T, Tominaga M, Kuroda Y, Saitoh Y (1993) A comparative study of tumor responses of hepatocellular carcinoma and colorectal hepatic metastasis to cytotoxic anticancer drug. Jpn J Cancer Chemother 20:1355–1361

    Google Scholar 

  21. Niederhuber JE, Ensminger WG, Thrall J, Walker S, Cozzi E (1984) Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 53:1336–1343

    Google Scholar 

  22. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685–693

    Google Scholar 

  23. Cohen AM, Greenfield A, Wood WC, Waltman A, Novelline R, Athanasoulis C, Scheeffer NJ (1983) Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer 51:2013–2019

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ku, Y., Tominaga, M., Iwasaki, T. et al. Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases. Surg Today 26, 305–313 (1996). https://doi.org/10.1007/BF00311598

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00311598

Key Words

Navigation